COVID‐19 immunopathology: from acute diseases to chronic sequelae
The clinical manifestation of coronavirus disease 2019 (COVID‐19) mainly targets the lung
as a primary affected organ, which is also a critical site of immune cell activation by severe …
as a primary affected organ, which is also a critical site of immune cell activation by severe …
Administration of COVID-19 vaccines in immunocompromised patients
Since the beginning of vaccination programs against COVID-19 in different countries,
several populations such as patients with specific immunological conditions have been …
several populations such as patients with specific immunological conditions have been …
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease …
Objective To update guidance regarding the management of psoriatic disease during the
COVID-19 pandemic. Study Design The task force (TF) includes 18 physician voting …
COVID-19 pandemic. Study Design The task force (TF) includes 18 physician voting …
Corticosteroids for COVID-19: the search for an optimum duration of therapy
GP Mishra, J Mulani - The Lancet Respiratory Medicine, 2021 - thelancet.com
Michael A Matthay and B Taylor Thompson1 have very nicely summarised the evidence-
based role of dexamethasone in hospitalised patients with COVID-19. Their pertinent …
based role of dexamethasone in hospitalised patients with COVID-19. Their pertinent …
Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: an …
X Xu, W Jiang, L Chen, Z Xu, Q Zhang… - Clinical and …, 2021 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) was identified in December 2019 and has …
syndrome coronavirus 2 (SARS‐CoV‐2) was identified in December 2019 and has …
Early versus late awake prone positioning in non-intubated patients with COVID-19
Background Awake prone positioning (APP) is widely used in the management of patients
with coronavirus disease (COVID-19). The primary objective of this study was to compare …
with coronavirus disease (COVID-19). The primary objective of this study was to compare …
Corticosteroids for COVID-19 ✩
D Annane - Journal of Intensive Medicine, 2021 - mednexus.org
Coronavirus disease 19 (COVID-19) is placing a major burden on healthcare, economy and
social systems worldwide owing to its fast spread and unacceptably high death toll. The …
social systems worldwide owing to its fast spread and unacceptably high death toll. The …
Use of steroids in COVID-19 patients: A meta-analysis
M Thakur, AK Datusalia, A Kumar - European Journal of Pharmacology, 2022 - Elsevier
Background Emerging reports have shown the benefits of steroids in hospitalized COVID-19
patients as life-saving drugs. However, the use of steroids in COVID-19 patients is confusing …
patients as life-saving drugs. However, the use of steroids in COVID-19 patients is confusing …
Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study
SA SeyedAlinaghi, L Abbasian, M Solduzian… - European Journal of …, 2021 - Springer
Background The clinical course of COVID-19 may vary significantly. The presence of
comorbidities prolongs the recovery time. The recovery in patients with mild-to-moderate …
comorbidities prolongs the recovery time. The recovery in patients with mild-to-moderate …
Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets-Magnifying global pandemic grieve and catastrophe begins
K Pushparaj, HK Bhotla, VA Arumugam… - Science of The Total …, 2022 - Elsevier
Post COVID-19, mucormycosis occurred after the SARS-CoV-2 has rampaged the human
population and is a scorching problem among the pandemic globally, particularly among …
population and is a scorching problem among the pandemic globally, particularly among …